ANNA CHAUVIN: Open Payments
NPI 1538728779 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 34 payments from 18 companies in 2025. Trend: 2023 $970 · 2024 $1,507 · 2025 $1,215
Food & beverage: $1,130Education: $85
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $254 |
| Sumitomo Pharma America, Inc. | 7 | $172 |
| GlaxoSmithKline, LLC. | 1 | $104 |
| GENZYME CORPORATION | 1 | $99 |
| Actelion Pharmaceuticals US, Inc. | 1 | $86 |
| SEAGEN INC. | 1 | $85 |
| PFIZER INC. | 4 | $77 |
| Janssen Biotech, Inc. | 5 | $69 |
| Innovation Technologies Inc | 2 | $44 |
| Dendreon Pharmaceuticals LLC | 2 | $40 |
Products named: GEMTESA, ETERNA, FREESTYLE LIBRE 3, XTANDI, DUPIXENT, UPTRAVI, ERLEADA, IRRISEPT.
Industry payments across LA — which companies pay providers there.
